Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04828824 · ClinicalTrials.gov registry record · Phase 4
Premature Discontinuation of Contraceptive Implants
A Phase 4 study of Contraception Behavior, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT04828824: Recruiting Phase 4 study of Contraception Behavior, sponsored by University of Colorado, Denver.
NCT04828824 is a Phase 4 study of Contraception Behavior that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 600 participants, below the 811-participant average among 11 other Contraception Behavior trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04828824, a Phase 4 study of Contraception Behavior, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).
Primary Outcome
We will assess continuation of use of the contraceptive implant.
Conditions Studied
Interventions
- DRUG Ethinyl Estradiol / Norgestimate Oral Tablet
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2021-06-18 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 4 |
What NCT04828824 shows while recruiting
NCT04828824 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 811-participant average among 11 other Contraception Behavior trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Contraception Behavior appearing as the primary indexed condition, and to 1 intervention - of which Ethinyl Estradiol / Norgestimate Oral Tablet is the first listed.
NCT04828824 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04828824 about?
NCT04828824 is a clinical study titled "Premature Discontinuation of Contraceptive Implants". To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).
What is the current status of trial NCT04828824?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 600 participants. The study started on 2021-06-18. Estimated completion is 2025-12-31.
What conditions does trial NCT04828824 study?
This clinical trial studies the following conditions: Contraception Behavior.
What interventions are being tested in trial NCT04828824?
The interventions under investigation include: Ethinyl Estradiol / Norgestimate Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT04828824?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04828824 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04828824's enrollment target sits among peer trials
600 7th of 11 higher than 5 of 11 other Contraception Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Patient-centered Information on Permanent Contraception
RECRUITING · NA
-
Effectiveness Testing of a Videogame Intervention (No Baby No) to Decrease Contraception Non-use Among Adolescents.
RECRUITING · NA
-
Evaluation of an Adolescent Pregnancy Prevention Program; Relationship Smarts+ With Lessons From Mind Matters
ACTIVE NOT RECRUITING · NA
-
The Over The Counter Pill National Study
ACTIVE NOT RECRUITING
-
Birth Control to Improve Birth Spacing
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI